Sifalin-TATE precursor (Acetate salt)
Precursor for [¹⁸F]Sifalin TATE
Sequence: SiFAlin-Aoa-Asn(AcNH-ß-Glc)-Asp-Asp-O2Oc-D-Phe-Cys-Tyr-D-Trp-Lys-Thr-Cys-Thr-OH, cyclic disulfide (SiFAlin: N-(4-(di-tert-butylfluorosilyl)benzyl)-N,N-dimethyl-4-oxobutan-1-ammonium acetate; Aoa: aminooxyacetic acid; Asn(AcNH-ß-Glc): N-β-[2-(acetylamino)-deoxy-2-β-glucopyranosyl]-L-asparagine; O2Oc: 8-amino-3,6-dioxaoctanoic acid)
Quality
Research Chemical
Characteristics
Molar mass 2163.5 (net peptide)
CAS RN [not yet assigned]
Purity ≥ 95 %
- White to off-white solid
- soluble in water
Certificates
CoA: HPLC (purity), HPLC-MS (identity)
Literature
Litau S. et al. Next Generation of SiFAlin-Based TATE Derivatives for PET Imaging of SSTR-Positive Tumors: Influence of Molecular Design on In Vitro SSTR Binding and In Vivo Pharmacokinetics. Bioconjug. Chem. 2015, 26, 2350–2359.
Niedermoser S. et al. In Vivo Evaluation of ¹⁸F-SiFAlin-Modified TATE: A Potential Challenge for ⁶⁸Ga-DOTATATE, the Clinical Gold Standard for Somatostatin Receptor Imaging with PET. J. Nucl. Med. 2015, 56, 1100–5.
Add to inquiry
Product | Product No. | Filling amount | Quantity | ||
---|---|---|---|---|---|
/products/small-molecules-and-peptides/chemical/c3608687-97a4-4d19-8a42-907795dadc64 | Precursor | Product No.: 97521 |